Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Assay and Drug Development Technologies|April 20, 2004
A "mix and read" assay for insulin using fluorometric microvolume assay technologyJeffrey H Toney, Aimie Ogawa, Megan Blair, et al.Acta Crystallographica. Section D, Structural Biology|May 13, 2026
Peptide binding at the gasdermin D exosite reveals the structural basis for targeting the siteRenjing Wang, Thu Ho, Aimie Ogawa, et al.ACS Medicinal Chemistry Letters|March 18, 2026
N‑Alkyl and N‑Aryl Aminopyrazole Spirocarbamates: A Two-Pronged Lead Optimization Strategy to Identify Orally Bioavailable Plasma Kallikrein InhibitorsRohan R Merchant, Natalia Chernyak, Jovan A Lopez, et al.Bioorganic & Medicinal Chemistry Letters|January 18, 2014
Discovery of MK-7655, a β-lactamase inhibitor for combination with Primaxin®Timothy A Blizzard, Helen Chen, Seongkon Kim, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|May 28, 2016
Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary TanglesEric D Hostetler, Abbas M Walji, Zhizhen Zeng, et al.Diabetes|November 4, 2017
Engineering Glucose Responsiveness Into InsulinNiels C Kaarsholm, Songnian Lin, Lin Yan, et al.Journal of Medicinal Chemistry|July 25, 2022
Optimization and Mechanistic Investigations of Novel Allosteric Activators of PKG1αVictor W Mak, Akash M Patel, Rose Yen, et al.Journal of Medicinal Chemistry|April 19, 2016
Discovery of 6-(Fluoro-(18)F)-3-(1H-pyrrolo[2,3-c]pyridin-1-yl)isoquinolin-5-amine ([(18)F]-MK-6240): A Positron Emission Tomography (PET) Imaging Agent for Quantification of Neurofibrillary Tangles (NFTs)Abbas M Walji, Eric D Hostetler, Harold Selnick, et al.Science (New York, N.Y.)|July 15, 2017
Systemic pan-AMPK activator MK-8722 improves glucose homeostasis but induces cardiac hypertrophyRobert W Myers, Hong-Ping Guan, Juliann Ehrhart, et al.Pageof 1